Modulation of chrysarobin skin tumor promotion

Area of Science:

• Oncology
• Dermatology
• Biochemistry

Background:

• Skin tumor promotion involves complex biochemical pathways.
• Understanding these pathways is crucial for developing effective chemopreventive strategies.
• Chrysarobin, an anthrone derivative, and phorbol esters are known skin tumor promoters.

Purpose of the Study:

• To investigate the inhibitory effects of prototypic phorbol ester tumor promoter inhibitors on skin tumor promotion induced by chrysarobin.
• To determine if common biochemical pathways are involved in skin tumor promotion by different chemical classes of promoters.

Main Methods:

• Mice were treated with chrysarobin (anthrone promoter) or 12-O-tetradecanoylphorbol-13-acetate (TPA, phorbol ester promoter).
• Inhibitors including retinoic acid (RA), fluocinolone acetonide (FA), and alpha-difluoromethylornithine (alpha-DFMO) were administered at various time points and concentrations.
• Skin tumor promotion, papilloma formation, and epidermal ornithine decarboxylase (ODC) activity were assessed.

Main Results:

• Retinoic acid (RA) significantly inhibited chrysarobin-induced skin tumor promotion, with inhibition dependent on the treatment protocol.
• Fluocinolone acetonide (FA) effectively inhibited chrysarobin-induced skin tumor promotion.
• Alpha-difluoromethylornithine (alpha-DFMO) inhibited both chrysarobin-induced epidermal ODC activity and papilloma formation, and also reduced papilloma size in TPA-treated mice.

Conclusions:

• RA, FA, and alpha-DFMO demonstrate potential as general inhibitors of skin tumor promoters across different chemical classes.
• The findings suggest the existence of common biochemical pathways mediating skin tumor promotion by both anthrone and phorbol ester compounds.
• These inhibitors may offer a broad-spectrum approach to chemoprevention of skin carcinogenesis.